Kulusevski return can spark Spurs: De Zerbi
Tottenham manager Roberto De Zerbi hopes Dejan Kulusevski's long-awaited return from injury will provide a boost...
Swedish opposition leader Andersson tasked with forming govt: parliament speaker
Sweden's parliament speaker said Friday that following post-election talks with party leaders he had tasked opposition chief Magdalena Andersson of the Social...
The case of Africa's 'vanishing' carbon deals
The case of Africa's 'vanishing' carbon deals
By AFP's Evelyn Kpadeh Seagbeh and Code for Africa's Kunle Adebajo
ChatEurope launches live video coverage to bring EU news closer to citizens
ChatEurope, the go-to platform for European affairs created by leading European media outlets, enhances its offer with the launch of key EU events live video coverage.
ChatEurope, the go-to platform for European affairs created by leading European media outlets, enhances its offer with the launch of key EU events live video coverage.
Paramount settles with US states to clear Warner Bros. mega-merger
Paramount has reached a settlement with a group of US states that clears the way for its takeover of Warner Bros. Discovery, officials announced Monday, creating a Hollywood...
OpenAI calls for US to lead global effort on AI standards
OpenAI on Monday called for the United States to lead a global effort on establishing standards for developing artificial intelligence as CEO Sam Altman prepares to brief...
South African ostriches plucked alive for luxury fashion: report
South African ostrich farms are using mechanical pluckers to remove feathers from living birds destined for major luxury fashion brands in techniques that are cruel and painful, animal welfare group...
Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 2026
Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at theEuropean Society for Medical Oncology (ESMO)Congress, taking place October 23-27, 2026, in Madrid, Spain. Key data will include a late-breaking abstract on arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343*) and two presentations on TAK-928 (Innovent R&D code: IBI363*). Clinical and real-world...
Anglais